Thrombotic microangiopathic nephropathy, pulmonary hypertension and nephromegaly: Case report of a patient treated with endothelin receptor antagonist

Clinical Nephrology

Volumn 77, Issue 2, 2012, Pages 164-170

  Losito, Attilio ^a   Pittavini, Loretta ^a   Covarelli, Carla ^a  

^a SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

Author keywords

Nephromegaly; Pulmonary hypertension; Thrombotic microangiopathy

Indexed keywords

AMLODIPINE; ANTITHROMBIN III; BOSENTAN; CREATININE; ENALAPRIL; HOMOCYSTEINE; PROSTACYCLIN; WARFARIN; ANTIHYPERTENSIVE AGENT; ENDOTHELIN RECEPTOR; SULFONAMIDE;

ADOLESCENT; AMINO ACID BLOOD LEVEL; ANTICOAGULANT THERAPY; ANTIHYPERTENSIVE THERAPY; ARTICLE; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIET RESTRICTION; DISEASE COURSE; ECHOCARDIOGRAPHY; ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOFLUORESCENCE; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY HYPERTROPHY; MALE; MEDICAL HISTORY; PROTEINURIA; PULMONARY HYPERTENSION; THROMBOTIC MICROANGIOPATHIC NEPHROPATHY; THROMBOTIC THROMBOCYTOPENIC PURPURA; DRUG ANTAGONISM; KIDNEY; PATHOLOGY;

ADOLESCENT; ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION, PULMONARY; KIDNEY; MALE; RECEPTORS, ENDOTHELIN; SULFONAMIDES; THROMBOTIC MICROANGIOPATHIES;

EID: 84859514587     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN106829     Document Type: Article

References (33)

1. Faustinella F, Uzoh C, Sheikh-Hamad D, Truong LD, Olivero JJ. Glomerulomegaly and proteinuria in a patient with idiopathic pulmonary hypertension. J Am Soc Nephrol. 1997; 8: 1966-1970.
2. Perkowska-Ptasinska A, Sulikowska-Rowinska A, Pazik J, Komuda-Leszek E, Durlik M. Thrombotic nephropathy and pulmonary hypertension following autologous bone marrow transplantation in a patient with acute lymphoblastic leukemia: case report. Transplant Proc. 2006; 38: 295-296.
3. Monsuez JJ, Auperin I, Vittecoq D, Heshmati F. Pulmonary hypertension associated with thrombotic thrombocytopaenic purpura in AIDS patients. Eur Heart J. 1997; 18: 1036-1037.
4. Levy GG, Nichols WC, Lian EC, Foroud T, Mc-Clintick JN, McGee BM, Yang AY, Siemieniak DR, Stark KR, Gruppo R, Sarode R, Shurin SB, Chandrasekaran V, Stabler SP, Sabio H, Bouhassira EE, Upshaw JD Jr, Ginsburg D, Tsai HM. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 2001; 413: 488-494.
5. Yeager ME, Halley GR, Golpon HA, Voelkel NF, Tuder RM. Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension. Circ Res. 2001; 88: E2-E11.
6. Sfikakis PP, Papamichael C, Stamatelopoulos KS, Tousoulis D, Fragiadaki KG, Katsichti P, Stefanadis C, Mavrikakis M. Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis. Arthritis Rheum. 2007; 56: 1985-1993.
7. Takahashi M, Nakamura T, Toba T, Kajiwara N, Kato H, Shimizu Y. Transplantation of endothelial progenitor cells into the lung to alleviate pulmonary hypertension in dogs. Tissue Eng. 2004; 10: 771-779.
8. Gladwin MT, Kato GJ. Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia. Hematology (Am Soc Hematol Educ Program). 2005. p. 51-57.
9. Connor P, Veys P, Amrolia P, Haworth S, Ashworth M, Moledina S. Pulmonary hypertension in children with Evans syndrome. Pediatr Hematol Oncol. 2008; 25: 93-98.
10. Labrune P, Zittoun J, Duvaltier I, Trioche P, Marquet J, Niaudet P, Odièvre M. Haemolytic uraemic syndrome and pulmonary hypertension in a patient with methionine synthase deficiency. Eur J Pediatr. 1999; 158: 734-739.
11. D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med. 1991; 115: 343-349.
12. Rosenzweig EB, Kerstein D, Barst RJ. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. Circulation. 1999; 99: 1858-1865.
13. McLaughlin VV, Sitbon O, Badesch DB, Barst RJ, Black C, Galiè N, Rainisio M, Simonneau G, Rubin LJ. Survival with first-line bosentan in patients with primary pulmonary hypertension. Eur Respir J. 2005; 25: 244-249.
14. Ribadeau-Dumas S, Tillie-Leblond I, Rose C, Saulnier F, Wemeau JL, Hatron PY, Wallaert B. Pulmonary hypertension associated with POEMS syndrome. Eur Respir J. 1996; 9: 1760-1762.
15. Fam AG, Rubenstein JD, Cowan DH. POEMS syndrome. Study of a patient with proteinuria, microangiopathic glomerulopathy, and renal enlargement. Arthritis Rheum. 1986; 29: 233-241.
16. Raife TJ, Lager DJ. Chronic thrombotic microangiopathy associated with antineoplastic therapy with minimal hematologic effects. Mayo Clin Proc. 2002; 77: 323-328.
17. De Serres SA, Isenring P. Athrombocytopenic thrombotic microangiopathy, a condition that could be overlooked based on current diagnostic criteria. Nephrol Dial Transplant. 2009; 24: 1048-1050.
18. DeBaun MR, Siegel MJ, Choyke PL. Nephromegaly in infancy and early childhood: a risk factor for Wilms tumor in Beckwith-Wiedemann syndrome. J Pediatr. 1998; 132: 401-404.
19. Pickering SP, Fletcher BD, Bryan PJ, Abramowsky CR. Renal lymphangioma: a cause of neonatal nephromegaly. Pediatr Radiol. 1984; 14: 445-448.
20. Di Fiori JL, Rodrigue D, Kaptein EM, Ralls PW. Diagnostic sonography of HIV-associated nephropathy: new observations and clinical correlation. AJR Am J Roentgenol. 1998; 171: 713-716.
21. Han BK, Babcock DS. Sonographic measurements and appearance of normal kidneys in children. AJR Am J Roentgenol. 1985; 145: 611-616.
22. Cheong B, Muthupillai R, Rubin MF, Flamm SD. Normal values for renal length and volume as measured by magnetic resonance imaging. Clin J Am Soc Nephrol. 2007; 2: 38-45.
23. Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, Groves BM, Tapson VF, Bourge RC, Brundage BH, Koerner SK, Langleben D, Keller CA, Murali S, Uretsky BF, Clayton LM, Jöbsis MM, Blackburn SD Jr, Shortino D, Crow JW; The Primary Pulmonary Hypertension Study Group. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med. 1996; 334: 296-302.
24. Fitzgerald GA, Maas RL, Stein R, Oates JA, Roberts LJ. Intravenous prostacyclin in thrombotic thrombocytopenic purpura. Ann Intern Med. 1981; 95: 319-322.
25. Rock G, Porta C, Bobbio-Pallavicini E. Thrombotic thrombocytopenic purpura treatment in year 2000. Haematologica. 2000; 85: 410-419.
26. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 1993; 328: 1732-1739.
27. Galiè N, Rubin Lj, Hoeper M, Jansa P, Al-Hiti H, Meyer G, Chiossi E, Kusic-Pajic A, Simonneau G. Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet. 2008; 371: 2093-2100.
28. Zakarija A, Bennett C. Drug-induced thrombotic microangiopathy. Semin Thromb Hemost. 2005; 31: 681-690.
29. Yamamoto T, Nagayama K, Satomura K, Honda T, Okada S. Increased serum IL-10 and endothelin levels in hemolytic uremic syndrome caused by Escherichia coli O157. Nephron. 2000; 84: 326-332.
30. Nangaku M, Yamada K, Gariepy CE, Miyata T, Inagi R, Kurokawa K, Yanagisawa M, Fujita T, Johnson RJ. ET(B) receptor protects the tubulointerstitium in experimental thrombotic microangiopathy. Kidney Int. 2002; 62: 922-928.
31. Dhaun N, Macintyre IM, Melville V, Lilitkarntakul P, Johnston NR, Goddard J, Webb DJ. Blood pressure-independent reduction in proteinuria and arterial stiffness after acute endothelin-a receptor antagonism in chronic kidney disease. Hypertension. 2009; 54: 113-119.
32. Vachiéry J-L, Davenport A. The endothelin system in pulmonary and renal vasculopathy: les liaisons dangereuses. Eur Respir Rev. 2009; 18: 260-271.
33. Wenzel RR, Littke T, Kuranoff S, Jürgens C, Bruck H, Ritz E, Philipp T, Mitchell A; SPP301 (Avosentan) Endothelin Antagonist Evaluation in Diabetic Nephropathy Study Investigators. Avosentan reduces albumin excretion in diabetics with macroalbuminuria. J Am Soc Nephrol. 2009; 20: 655-664.